Suchen Sie nach Informationen zu Hauptsitz Von Sorrento Therapeutics? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.dnb.com/business-directory/company-profiles.sorrento_therapeutics_inc.253c9966ea4a88200cd014c9c9619865.html
https://sorrentotherapeutics.com/
Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19
https://rocketreach.co/sorrento-therapeutics-inc-profile_b5ceba64f42e09ae
Sorrento Therapeutics is a development-stage biopharmaceutical company engaged in the acquisition, discovery, development and commercialization of proprietary drug therapeutics for addressing significant unmet medical needs. Sorrento’s late stage pipeline include Cynviloq™ (paclitaxel in polymeric micelle formulation) currently in a registrational bio-equivalent study …
https://www.datanyze.com/companies/sorrento-therapeutics/353909247
Sorrento Therapeutics Profile and History. Founded in 1989, Sorrento Therapeutics is a clinical-stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers. The company is headquartered in San Diego, California.
https://www.dnb.com/business-directory/company-profiles.sorrento_therapeutics_inc.253c9966ea4a88200cd014c9c9619865.html
Company Description: Sorrento Therapeutics, Inc. is located in San Diego, CA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Sorrento Therapeutics, Inc. has 799 total employees across all of its locations and generates $52.90 million in sales (USD). There are 30 companies in the Sorrento Therapeutics, Inc ...
https://www.swfinstitute.org/profile/5e39a5cefcbe7e8ca7259219
Sorrento Therapeutics, Inc. (Sorrento Therapeutics) is a Pharmaceutical Company located in San Diego, CA United States, North America, and was founded in 2006. Current Assets for Sorrento Therapeutics is $536,553,000 and SWFI has 2 periods of historical assets available for CSV Export. Request Profile Update; Download Data
https://craft.co/sorrento-therapeutics
Sorrento Therapeutics is a biopharmaceutical company engaged in the acquisition, discovery, development and commercialization of proprietary drug therapeutics for addressing significant unmet medical needs. Sorrento's primary therapeutic focus is cancer although its products and technologies have much broader clinical applications including autoimmune …
https://www.marketscreener.com/quote/stock/SORRENTO-THERAPEUTICS-IN-14708339/company/
The Company’s segments include Sorrento Therapeutics and Scilex. Sorrento Therapeutics segment is organized around Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate cancer therapeutics. The Scilex segment is largely organized around its non-opioid pain management operations.
https://www.bloomberg.com/profile/company/SRNE:US
Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and …
https://sorrentotherapeutics.com/de/who-we-are/leadership/
Sorrento Therapeutics - Wir wenden modernste Wissenschaft an, um innovative Therapien zu entwickeln, die das Leben von Menschen verbessern, die an Krebs, hartnäckigen Schmerzen und COVID-19 leiden
https://sorrentotherapeutics.com/de/affiliates/
Sorrento Therapeutics - Wir wenden modernste Wissenschaft an, um innovative Therapien zu entwickeln, die das Leben von Menschen verbessern, die an Krebs, hartnäckigen Schmerzen und COVID-19 leiden
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Sorrento Therapeutics gefunden haben.
